- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 107.38M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $225.8M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $222.5M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $220.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $143M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.72B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.57B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.05B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.85B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.62B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $4.82B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 109.2M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $12.9M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.33B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.33B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.05 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $106.5M |
| Net Income | Q1 2025 · Mar 31, 2024 | $18.5M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $36.8M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $429.9M |